Table 7 |
|||
|
Proteinuria during DSG treatment: proteinuria (g/day) in the study population (n = patient number) |
|||
|
Patient number (n) |
Proteinuria (study population) |
P-value compared to entry |
|
|
|
|||
|
Entry |
20 |
5.124 +/- 4,379 |
|
|
cycle 4 |
20 |
2.604 +/- 2,580 |
0.0045 |
|
cycle 6 |
14 |
2.603 +/- 2,521 |
0.0392 |
|
cycle 9 |
12 |
3.374 +/- 4,787 |
0.028 |
|
|
|||
|
DSG, deoxyspergualin |
|||
|
Lorenz et al. Arthritis Research & Therapy 2011 13:R36 doi:10.1186/ar3268 |
|||
